Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Poster Exhibitions

Monda l-u 8

Poster Exhbiton MnIa Iul 8Ay)A%

MoPeC3334 Causes of death in persons with AIDS in San
Francisco in the era of highly active antiretroviral
therapy (HAART): 1994-1998
J K Louie, L C Hsu, D H Osmond M H Katz,
S K Schwarcz (United States)
MoPeC3335 Reasons for attendance at emergency
department in patients controlled by a substance
abuse treatment center
M TAlvarez A Soler, M Ribell, I Andres, J L Simon,
E Pedro/ (Spain)
MoPeC3336 Trends in mortality in persons with HIV, CORE
Center, Chicago, 1996-2ooo000
M H Cohen L Green, R Sherer (United States)
MoPeC3337 Changing trends in causes of death by gender in
Chicago since HAART, 1996-1999
L Green, M H Cohen, J Pulvirenti, R Sherer
(United States)
MoPeC3338 All-cause mortality rates in HIV infected patients in
the years 1987- 2000 in the COMESEM Cohort Study
J L Prez Quero, G Gaspar, J Gdmez Rodrigo,
J Sanz, C Barros, V Castilla, J CAlberdi (Spain)
MoPeC3339 Impact of AIDS on mortality in Pointe-Noire, Congo
S Le Coeur', G E Halembokaka2, J B Douma',
F Purhuence2, M Sibi2, B Ndala2, P Koulou2,
M Matete2 (iFrance; 2Congo)
MoPeC334o Pre and post HAART era survival and
antiretroviral use among HIV-infected injection
drug users at different CD4 strata
J C Bareta', N GalaP, S A Strathdeel, S Cohn',
J B Margolick', T Sterling', D Vlahovy'
('United States; 2Israel)
MoPeC3341 Child mortality associated with reasons for nonbreastfeeding and weaning: policy implications
for breastfeeding by HIV positive mothers
R H G Gray, H P B Brahmbhatt (United States)
MoPeC3342 Trends over time in virological response to first
highly active antiretroviral treatment regimen
F C Lampe, CA Sabin, MA Johnson, M Youle,
A N Phillips (United Kingdom)
MoPeC3343 Spatial-temporal trends of the AIDS epidemic in
the city of Recife, Brazil, 1985-2000
AM Brito W V Souza, G C Gouveia, 0 G Cruz,
F Figueiroa, D Sena, R P Santos (Brazil)
MoPeC3344 Study of admissions in HIV patients. 13 years of
follow up
C Redondo, G Poza, C Galera, H Gomez,
J Ruiperez (Spain)
MoPeC3345 HIV infection among heterosexuals, men who
have sex with men, and immigrants in Denmark.
HIV infection detection rates, 1990-2ooo000
A Lemcke, J Duus Johansen, E Smith (Denmark)
MoPeC3346 Gender differences in mortality and morbidity in
perinatally HIV-infected children in New York City
K L Liu V Peters, I Weedon, A Brooks, C Mapson,
P Thomas (United States)
MoPeC3347 Psychometric properties of the Multidimensional
Quality of Life Questionnaire for Persons Infected
with HIV or with AIDS in a cohort of HIV-infected
women
VP Remple, B A Hilton, E Maan, D R Burdge
(Canada)
MoPeC3348 Drug use, sexual behavior and HIV infection
among women in Guangxi, China
W Liu', Q Y Zhu', F Y Liu', I Chen', N Z Guo', D C
Huang', X F Yu2, C Beyrer2 China; 2United States)
MoPeC3349 Intimate partner violence and sexual HIV-risk

behavior among women on methadone
N El-Bassel L Gilbert, E Wu, H Go, J Hill,
B L Richman, RF Schilling (United States)

MoPeC335o Contraceptive Use and Knowledge in South
Africa: Evidence from the 1998 South African
Demographic and Health Survey (SADHS)
KM Moshia (South Africa)
MoPeC3351 A gender comparison of HIV and drug use across
the rural-urban continuum
C B McCoy, L R Metsch, S E Messiah, S Lai,
H V McCoy (United States)
MoPeC3352 Work determinants of male and female youth
mobile workers in Hanoi - Vietnam: implication of
HIV/AIDS risk from gender perspective
A Hoang Tu Anh (Vietnam)
MoPeC3353 HIV risk behaviors during one year follow-up
among a cohort of female drug user (DU) in
northern Thailand
N Srirak', S Kawichai', M H Razak', 0 Short',
U Timpan', V Suriyanon', J Jittiwuttikarn',
D D Celentano2 (Thailand; 2 United States)
MoPeC3354 Prevalence and correlates of neutropenia among
a large cohort of HIV infected women and HIV
negative women at risk: Women's Interagency
HIV Study (WIHS).
A M Levine, CM Ervin, S JGange, K Anastos,
M Young, M Cohen, M Newman, M Augenbraun,
H Watts (United States)
MoPeC3355 Reproductive health among women at high risk of
HIV infection
A E Weber M W Tyndall, S Coulter, K Chan, K Li,
M T Schechter (Canada)
MoPeC3356 Effectiveness of an HIV risk reduction
intervention among African American women who
use crack
K W Elifson, CE Sterk, K P Theall (United States)
MoPeC3357 Women with HIV in India
A Sud, U Dutta, A Wanchu, P Bambery, S Singh
(India)
MoPeC3358 Estimated HIV seroincidence in women
consulting for an HIV infection at a hospital in
Buenos Aires, Argentina
M Vignoles', J Benetucci', H W Sheppard2, S Sosa
Estani', D Garone', V Galache', M Weissenbacher'
(Argentina; 2United States)
MoPeC3359 Risky Injection practices among IDU women who
have sex with women (WSW)
C Hankins C Blanchette, M Alary, R Parent,
C Claessens (Canada)
MoPeC336o Detection of human papillomavirus (HPV) DNA in
HIV-Infected women: comparison of self-obtained
vaginal Swab and physician-obtained cervical
Swab samples
F Coutlee, C Hankins, S Walmsley, D Money,
K Pourreaux, P Forest, ] 0 Shu (Canada)
MoPeC3361 Gender differences in sexual behaviour among
young heroin users in Madrid, Barcelona and
Seville, 2001 (preliminary results from ITINERE
project)
G Barrio, G Le laie, L Domingo, T C Silva, E Dfaz,
M Hornllo, A Fabregat (Spain)
MoPeC3362 Why men should make a difference: the case for
Tanzania
M mshana (Tanzania)
MoPeC3363 Gender differences in HIV infection among
individuals seen at counseling and testing
centers in Sao Paulo, Brazil, 2000-2001
MA S Veras, K Bassichetto, F Mesquita,
N A Paneque, S V Carvalho, PS Zular, L G Pinto,
S Oliveira, D P Bergamashi (Brazil)

Monday

XIV International AIDS Conference BARCELONA - JULY 7-12

43